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Division of Pediatric Infectious Diseases and the Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USACutaneous abscesses are some of the most common manifestations
of bacterial infections. Abscesses can present as transient painful
lumps that resolve without medical intervention, or in severe cases as
large deep abscesses associated with bloodstream dissemination.
Although many Gram-positive and Gram-negative bacteria cause
abscesses, S. aureus, in particular community-associated MRSA, is the
most common causative agent. Once formed, the pus in the walled-off
lesion can signiﬁcantly interfere with the activity of antibiotics to the
extent to make antibiotic treatment moderately ineffective when an
abscess exceeds a certain size, with scarring posing as an additional
problem. In this issue of EBioMedicine (Mansour et al., 2016–in this
issue), Hancock and colleagues describe a cationic peptide that primar-
ily targets the formation of abscesses. The peptidewas developed from a
screen of anti-bioﬁlm peptides (de la Fuente-Nunez et al., 2015)
and in vitro prevented or eradicated bioﬁlms formed by both Gram-
positive and Gram-negative bacteria. In non-vertebrate models of
P. aeruginosa infection, it enhanced survival of the host (de la Fuente-
Nunez et al., 2015).
The target of the cationic peptide is the conserved bacterial stringent
stress response mediator (p)ppGpp (De La Fuente-Nunez et al., 2014,
2015). Cellular concentrations of pppGpp and ppGpp increase when
bacteria are exposed to stresses, speciﬁcally nutrient limitation.
(p)ppGpp, as a pleiotropic transcriptional regulator, orchestrates
reprogramming of cellular processes by slowing the growth rate and
pushes energy to be used formaintenance and stress-defense, including
bioﬁlm formation (Wolz et al., 2010). This is known as the stringent
response and is an important bacterial survival mechanism. The
enzymes responsible for synthesizing and degrading (p)ppGpp are
highly conserved among bacteria. In Gram-negative bacteria,
(p)ppGpp is synthesized by RelA and degraded by SpoT (Metzger
et al., 1989). In Gram-positive bacteria, the RelA/SpoT Homologue
(RSH) bifunctional proteins are the main enzymes responsible for
synthesizing (p)ppGpp from ATP and GTP/GDP and hydrolyzing
(p)ppGpp into GTP/GDP and pyrophosphate (Wendrich and Marahiel,
1997).
In the current study (Mansour et al., 2016–in this issue), Hancock
and colleagues further tested inhibition of the bacterial stringent re-
sponse in murine models of S. aureus and P. aeruginosa cutaneousDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.09.015.
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(stringent response mutant) or the universal stress protein Usp2 in-
duces signiﬁcantly smaller abscesses and cutaneous lesions compared
towild type S. aureus, without an effect on bacterial burden. Local or sys-
temic application of a previously characterized stringent-response in-
hibitor peptide DJK-5 (de la Fuente-Nunez et al., 2015), at the time or
shortly after S. aureusor P. aeruginosa infection, also blocked abscess for-
mation with modest or no effect on bacterial burden. DJK-5 blockade of
abscess correlated in vitro to inhibition of one S. aureus virulence deter-
minant, phenol-soluble modulin (PSMα), which has been shown previ-
ously to be important for cutaneous lesion formation (Berube et al.,
2014). Although DJK-5 has antimicrobial activity that is thought to be
related to its cationic property, use of sub-MIC peptide dosing and mu-
tant bacteria defective in stringent response in vivo helped to dissociate
killing of the bacteria as themechanism driving the inhibition of abscess
formation.
A fundamental question that arises from the study is the relation
between the stringent response and abscess formation. The mecha-
nisms responsible for abscess formation have been an important topic
of research in the S. aureus ﬁeld. While certain stress defense
mechanisms, such as metal limitation, oxidative, and nitric stress seem
to have a role in the ability of S. aureus to form abscesses, the stringent
response in this context has yet to be elucidated. It is likely that a prima-
ry connection is due to the stringent response's direct effect on regulator
CodY. CodY has been shown to impact disease severity in several animal
models by altering expression of master regulators, like agr (RNAIII and
RNAII) and saeR, hemolysins (hla), leukocidins (lukSF), capsule synthe-
sis (icaADBC), as well as many other genes shown to be important for
abscess formation (Majerczyk et al., 2008). PSMα expression, which is
shown to be inhibited by DJK-5, is up-regulated via RSH independently
of CodY (Geiger et al., 2012). The speciﬁc factors regulating abscess
formation under the stringent response remain to be determined in S.
aureus and other microbes.
From a clinical angle, blockade of abscess formation would be a
potentially useful adjunct to killing of the pathogens. Most frequently,
infected individuals present already with a large abscess that requires
surgical drainage. For those presenting with smaller or early stage
abscesses that are not yet amenable to surgical drainage, antibiotics
are routinely used but may not be sufﬁcient to stop progression of
abscess formation, particularly if the offending pathogen is relatively
antibiotic resistant. Inhibition of the stringent response to block abscess
formation could prove to be useful, and would compare to thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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treatment of toxin-mediated infections (Steer et al., 2012). The inhibi-
tors would be particularly useful if they also prevent chronic or recur-
rent abscesses including hard-to-treat S. aureus-related conditions
such as hidradenitis suppurativa. Future studies will need to establish
that the inhibitors are still effective when used in combination
with effective or marginally effective antibiotics.
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